ClinicalTrials.gg
Sign In

Anemia, Refractory, with Excess of Blasts clinical trials

This page lists the studies that name Anemia, Refractory, with Excess of Blasts. ClinicalTrials.gov files more under this term, 318 on November 8, 2026, through its term mapping. Most others are about myelodysplastic syndromes or acute myeloid leukemia in general. Myelodysplastic Syndromes studies →

The registry lists 65 studies for Anemia, Refractory, with Excess of Blasts across more than 10 countries. 6 are recruiting or about to start. 9 of them are mainly about Anemia, Refractory, with Excess of Blasts (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.

Get an email when these change. Save the Anemia, Refractory, with Excess of Blasts studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
43
Terminated
10
Recruiting
6
Active, not recruiting
5
Withdrawn
1

Phase

Phase 2
34
Phase 1
30
Phase 3
8

Where

United States
62
United Kingdom
4
Canada
4
Germany
4
Italy
3
France
3

Who runs them

National Cancer Institute (NCI) (22) · Fred Hutchinson Cancer Center (15) · M.D. Anderson Cancer Center (6) · Traws Pharma, Inc. (3) · University of Washington (3) · Masonic Cancer Center, University of Minnesota (2) · Eastern Cooperative Oncology Group (1) · Sidney Kimmel Cancer Center at Thomas Jefferson University (1)

Coming up

0phase 3 studies under way
7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Who these studies take

Of the 6 Anemia, Refractory, with Excess of Blasts studies recruiting now, 3 (50%) set no upper age limit and 2 (33%) stop at 75 or younger. 2 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
100 (0%)0 (0%)
186 (100%)6 (100%)
306 (100%)6 (100%)
406 (100%)6 (100%)
506 (100%)6 (100%)
656 (100%)6 (100%)
756 (100%)6 (100%)
853 (50%)3 (50%)

Across all 65 studies, recruiting or not: 34% stop at 75 or younger and 22% at 65; 31% take children; 0% are for women only and 0% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting2

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 65. Browse all 65 → or search them.